EXELIXIS INC's ticker is EXEL and the CUSIP is 30161Q104. A total of 335 filers reported holding EXELIXIS INC in Q4 2019. The put-call ratio across all filers is 0.79 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $1,038,000 | +307.1% | 51,729 | +396.8% | 0.10% | +215.2% |
| Q3 2020 | $255,000 | -36.4% | 10,412 | -38.4% | 0.03% | -38.9% |
| Q2 2020 | $401,000 | +2.3% | 16,910 | -23.7% | 0.05% | +45.9% |
| Q3 2019 | $392,000 | +292.0% | 22,177 | +375.2% | 0.04% | +428.6% |
| Q2 2019 | $100,000 | -33.8% | 4,667 | -26.2% | 0.01% | -41.7% |
| Q1 2019 | $151,000 | -95.6% | 6,325 | -96.1% | 0.01% | -81.5% |
| Q2 2018 | $3,452,000 | -2.8% | 160,397 | 0.0% | 0.06% | -4.4% |
| Q1 2018 | $3,553,000 | -72.0% | 160,397 | -61.5% | 0.07% | -71.4% |
| Q4 2017 | $12,675,000 | +30.0% | 416,956 | +3.6% | 0.24% | +25.9% |
| Q3 2017 | $9,753,000 | +6672.9% | 402,528 | +6771.4% | 0.19% | +6200.0% |
| Q2 2017 | $144,000 | – | 5,858 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 15,966,038 | $282,918,000 | 60.81% |
| NEXTHERA CAPITAL LP | 1,735,030 | $30,745,000 | 5.89% |
| GREAT POINT PARTNERS LLC | 2,075,000 | $36,769,000 | 5.73% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 704,534 | $9,574,000 | 4.55% |
| Matrix Capital Management Company, LP | 10,000,000 | $177,200,000 | 4.38% |
| Consonance Capital Management LP | 3,879,050 | $68,737,000 | 3.70% |
| Rhenman & Partners Asset Management AB | 1,261,414 | $22,352,000 | 2.24% |
| BB BIOTECH AG | 2,785,000 | $49,350,000 | 1.31% |
| CAPITAL MANAGEMENT CORP /VA | 285,575 | $5,060,000 | 1.29% |
| TEALWOOD ASSET MANAGEMENT INC | 155,376 | $2,753,000 | 1.03% |